These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Ticlopidine hydrochloride: its current use in cerebrovascular disease. Bronstein KS; Chadwick LR Rehabil Nurs; 1994; 19(1):17-20. PubMed ID: 8159859 [TBL] [Abstract][Full Text] [Related]
27. Ticlopidine for the prevention of thromboembolic stroke. Cowan S Axone; 1992 Dec; 14(2):58-9. PubMed ID: 1493112 [No Abstract] [Full Text] [Related]
29. Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease. Droste DW; Sonne M; Siemens HJ; Kaps M Neurol Res; 1996 Oct; 18(5):449-53. PubMed ID: 8916060 [TBL] [Abstract][Full Text] [Related]
30. Antiplatelet therapy in the prevention of stroke. Easton JD Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215 [TBL] [Abstract][Full Text] [Related]
31. Current use of antiplatelet drugs in stroke syndromes in the USA. Nelson E Ann N Y Acad Sci; 1990; 598():368-75. PubMed ID: 2248449 [No Abstract] [Full Text] [Related]
32. Ticlopidine and fatal aplastic anemia in an elderly woman. Mallet L; Mallet J Ann Pharmacother; 1994 Oct; 28(10):1169-71. PubMed ID: 7841572 [TBL] [Abstract][Full Text] [Related]
33. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study. Harbison JW Stroke; 1992 Dec; 23(12):1723-7. PubMed ID: 1448821 [TBL] [Abstract][Full Text] [Related]
34. New modalities and aspects of antiplatelet therapy for stroke prevention. Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097 [TBL] [Abstract][Full Text] [Related]
35. [Preventive treatment of cerebrovascular accidents of arterial origin]. Castillo V; Bogousslavsky J; Vuadens P Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Oster G; Huse DM; Lacey MJ; Epstein AM Stroke; 1994 Jun; 25(6):1149-56. PubMed ID: 8202972 [TBL] [Abstract][Full Text] [Related]
37. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122 [TBL] [Abstract][Full Text] [Related]
38. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. Hass WK; Easton JD; Adams HP; Pryse-Phillips W; Molony BA; Anderson S; Kamm B N Engl J Med; 1989 Aug; 321(8):501-7. PubMed ID: 2761587 [TBL] [Abstract][Full Text] [Related]
39. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters]. Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982 [TBL] [Abstract][Full Text] [Related]